A detailed history of American Capital Management Inc transactions in Bio Techne Corp stock. As of the latest transaction made, American Capital Management Inc holds 1,016,556 shares of TECH stock, worth $72.7 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares
1,016,556
Previous 960,092 5.88%
Holding current value
$72.7 Million
Previous $74.1 Million 3.41%
% of portfolio
2.3%
Previous 2.54%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $3.73 Million - $4.35 Million
56,464 Added 5.88%
1,016,556 $71.6 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $2.08 Million - $3.08 Million
39,393 Added 4.28%
960,092 $74.1 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $1.36 Million - $1.81 Million
20,191 Added 2.24%
920,699 $62.7 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $1.01 Million - $1.18 Million
13,681 Added 1.54%
900,508 $73.5 Million
Q1 2023

May 03, 2023

BUY
$71.62 - $86.62 $1.45 Million - $1.75 Million
20,227 Added 2.33%
886,827 $65.8 Million
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $54.5 Million - $238 Million
675,354 Added 353.13%
866,600 $71.8 Million
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $631,194 - $875,392
-2,234 Reduced 1.15%
191,246 $54.3 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $228,127 - $317,902
707 Added 0.37%
193,480 $67.1 Million
Q1 2022

May 16, 2022

BUY
$353.85 - $487.79 $1.06 Million - $1.46 Million
2,992 Added 1.58%
192,773 $83.5 Million
Q4 2021

Feb 14, 2022

SELL
$456.15 - $525.06 $527,765 - $607,494
-1,157 Reduced 0.61%
189,781 $98.2 Million
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $335,876 - $406,854
755 Added 0.4%
190,938 $92.5 Million
Q2 2021

Aug 13, 2021

BUY
$387.35 - $450.26 $1 Million - $1.16 Million
2,586 Added 1.38%
190,183 $85.6 Million
Q1 2021

May 17, 2021

BUY
$314.62 - $411.0 $225,582 - $294,687
717 Added 0.38%
187,597 $71.6 Million
Q4 2020

Feb 16, 2021

SELL
$246.9 - $321.87 $323,685 - $421,971
-1,311 Reduced 0.7%
186,880 $59.3 Million
Q3 2020

Nov 16, 2020

SELL
$232.22 - $282.96 $298,170 - $363,320
-1,284 Reduced 0.68%
188,191 $46.6 Million
Q2 2020

Aug 13, 2020

BUY
$185.43 - $279.56 $921,401 - $1.39 Million
4,969 Added 2.69%
189,475 $50 Million
Q1 2020

May 15, 2020

BUY
$161.17 - $221.51 $12.5 Million - $17.2 Million
77,841 Added 72.98%
184,506 $35 Million
Q4 2019

Feb 12, 2020

BUY
$189.68 - $222.09 $259,861 - $304,263
1,370 Added 1.3%
106,665 $23.4 Million
Q3 2019

Nov 14, 2019

SELL
$183.56 - $216.72 $37,262 - $43,994
-203 Reduced 0.19%
105,295 $20.6 Million
Q2 2019

Nov 14, 2019

BUY
$188.72 - $215.43 $75,488 - $86,172
400 Added 0.38%
105,498 $22 Million
Q2 2019

Aug 12, 2019

BUY
$188.72 - $215.43 $38,310 - $43,732
203 Added 0.19%
105,098 $21.9 Million
Q1 2019

May 14, 2019

BUY
$136.09 - $200.44 $521,224 - $767,685
3,830 Added 3.79%
104,895 $20.8 Million
Q4 2018

Feb 08, 2019

BUY
$132.75 - $203.8 $10.5 Million - $16.2 Million
79,312 Added 364.6%
101,065 $14.6 Million
Q3 2018

Nov 02, 2018

BUY
$147.44 - $204.11 $16,218 - $22,452
110 Added 0.51%
21,753 $4.44 Million
Q2 2018

Jul 17, 2018

BUY
$144.9 - $165.58 $14,490 - $16,558
100 Added 0.46%
21,643 $3.2 Million
Q1 2018

Apr 23, 2018

BUY
$131.46 - $151.04 $1.37 Million - $1.57 Million
10,400 Added 93.33%
21,543 $3.25 Million
Q4 2017

Apr 05, 2018

SELL
$121.17 - $134.75 $9,693 - $10,780
-80 Reduced 0.71%
11,143 $1.44 Million
Q4 2017

Jan 23, 2018

BUY
$121.17 - $134.75 $196,295 - $218,295
1,620 Added 16.87%
11,223 $1.45 Million
Q3 2017

Apr 05, 2018

SELL
$113.59 - $123.78 $9,087 - $9,902
-80 Reduced 0.83%
9,603 $1.16 Million
Q3 2017

Oct 20, 2017

BUY
$113.59 - $123.78 $20,786 - $22,651
183 Added 1.93%
9,683 $1.17 Million
Q2 2017

Apr 19, 2018

BUY
N/A
215 Added 2.32%
9,500 $1.12 Million
Q1 2017

Apr 18, 2018

BUY
N/A
9,285
9,285 $944,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.81B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track American Capital Management Inc Portfolio

Follow American Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Management Inc with notifications on news.